Physician
Internal Medicine
Dr. Camilo Jimenez, MD
|
|
Give Review
Camilo Jimenez practices Internal Medicine. He studied medicine at Baylor College of Medicine. He over the years received 1 awards: "Regional Top Doctor". Camilo Jimenez is a published doctor. He published 33 publications, including: 'Hepatocyte growth factor/cMET pathway activation enhances cancer hallmarks in adrenocortical carcinoma.' He accepts Medicare.
Publications
- Preexisting Adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis.
- Hepatocyte growth factor/cMET pathway activation enhances Cancer hallmarks in adrenocortical carcinoma.
- Efficacy and tolerability of vemurafenib in patients with BRAF(V600E) -positive papillary Thyroid cancer: M.D. Anderson Cancer Center off label experience.
- Medullary Thyroid Cancer in the Era of Tyrosine Kinase Inhibitors: To Treat or Not to Treat-And with Which Drug-Those Are the Questions.
- Role of salvage targeted therapy in differentiated Thyroid cancer patients who failed first-line sorafenib.
- THERAPY OF Endocrine DISEASE: Treatment of malignant pheochromocytoma and paraganglioma.
- Update on Medullary Thyroid Cancer.
- Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer.
- Prevalence by Age and Predictors of Medullary Thyroid Cancer in Patients with Lower Risk Germline RET Proto-Oncogene Mutations.
- Clinical and Radiological Features of Pheochromocytoma/Ganglioneuroma Composite Tumos: A Case Series with Comparative Analysis.
- Impact of Surgical Resection for Subdiaphragmatic Paragangliomas.
- Adrenocortical carcinoma: Clinical outcomes and prognosis of 330 patients at a tertiary care center.
- The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2.
- Genetic testing in head and neck paraganglioma: who, what, and why?
- Adrenal Ganglioneuroma: Features and outcomes of 27 cases at a referral cancer center.
- Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma.
- Bone Metastases and Skeletal-Related Events in Patients with Malignant Pheochromocytoma and Sympathetic Paraganglioma.
- Long-term outcomes of surgical treatment for hereditary pheochromocytoma.
- Reduced risk of colorectal Cancer with use of oral bisphosphonates: a systematic review and meta-analysis.
- Robotic-assisted retroperitoneoscopic Adrenalectomy: making a good procedure even better.
- The Noninvestigational Use of Tyrosine Kinase Inhibitors in Thyroid Cancer: Establishing a Standard for Patient Safety and Monitoring.
- A Retrospective Cohort Analysis of the Efficacy of Adjuvant Radiotherapy after Primary Surgical Resection in Patients with Adrenocortical Carcinoma.
- Treatment with Sunitinib for Patients with Progressive Metastatic Pheochromocytomas and Sympathetic Paragangliomas.
- Older patients with primary hyperparaThyroidism have greater than age predicted functional deficits.
- Preoperative serum osteocalcin may predict postoperative elevated paraThyroid hormone in patients with primary hyperparaThyroidism.
- 18FFluorodeoxyglucose Positron Emission Tomography-Guided Therapy in Metastatic Adrenocortical Carcinoma: An Illustrative Case.
- Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Linda...
- Preoperative vitamin D replacement therapy in primary hyperparaThyroidism: safe and beneficial?
- Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: iden...
- Posterior retroperitoneoscopic Adrenalectomy: preferred technique for removal of benign tumors and isolated metastases.
- Mitotane-induced Hyperlipidemia: a retrospective cohort study.
- A miRNA signature associated with human metastatic medullary Thyroid carcinoma.
Conditions Treated
- Abnormal Thyroid
- Acromegaly and Gigantism
- Adrenal Incidentaloma
- Adrenal Insufficiency
- View All
Doctors Specialties
- Internal Medicine
Accepted Insurances
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Emblem Health
- First Health (Coventry Health Care) PPO
- Medicare Advantage PFFS
- Choice Care PPO
- Medicare MCR
- Molina
- MultiPlan PPO
- PHCS Network PPO
- Old Surety Life Insurance CompanyMedicare MCR
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
Education
-
Baylor College of Medicine -
Jackson Memorial Hospital - Jackson Health System -
Pontifical Xavierian University
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1275614372 | |
| NPPES Provider LastName | JIMENEZ | |
| NPPES Provider FirstName | CAMILO | |
| NPPES Provider ZIPCode | 770304095 | |
| NPPES Provider State | TX | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 569.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275614372 |
| Last Name Of The Provider | JIMENEZ |
| First Name Of The Provider | CAMILO |
| View All |
Similar Doctors
|
|
Dr. Luda Kamenetsky, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samir M. Haq, MD |
|
|
Dr. Jamise R. Crooms, MD |
|
|
Dr. Andrew Jackson, MD |
|
|
Dr. Mark S. Pollet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anitha R. Gowda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adil R. Cheema, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristen M. Gateno, MD
This Doctor is OpenDoctor Recommended.
|